About Retinal ciliopathy due to mutation in the RPGR gene
Retinal ciliopathy due to mutation in the RPGR gene is a rare disease catalogued by Orphanet (ORPHA:156171). Search below for active recruiting clinical trials from ClinicalTrials.gov, or visit the Orphanet expert page for specialist centres, natural history studies, and patient registries worldwide.
Clinical Trial Eligibility Tips
What to know before applying to Retinal ciliopathy due to mutation in the RPGR gene trials.
Search ClinicalTrials.gov for "Retinal ciliopathy due to mutation in the RPGR gene" or Orphanet code ORPHA:156171 to find disease-specific recruiting studies.
Ask your specialist to refer you to an Orphanet-accredited Centre of Expertise for this condition.
Natural history studies and patient registries often open enrolment before drug trials — contact the Orphanet patient community first.
Patient Resources
Find recruiting Retinal ciliopathy due to mutation in the RPGR gene trials
Search 500,000+ studies from ClinicalTrials.gov, filtered for Retinal ciliopathy due to mutation in the RPGR gene. Updated daily.